OWMIAS
NRXP icon

One Wealth Management Investment & Advisory Services’s NRX Pharmaceuticals NRXP Stock Holding History

One Wealth Management Investment & Advisory Services’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177K Hold
43,309
– – 0.19% 52
2026
Q1 		$92.2K Buy
43,309
+5,436
+14% +$11K 0.11% 52
2025
Q4 		$103K Buy
37,873
+9,882
+35% +$26.5K 0.11% 50
2025
Q3 		$92.4K Buy
27,991
+12,950
+86% +$37.1K 0.11% 49
2025
Q2 		$49K Hold
15,041
– – 0.06% 47
2025
Q1 		$30.8K Hold
15,041
– – 0.05% 47
2024
Q4 		$33.1K Hold
15,041
– – 0.05% 46
2024
Q3 		$25.4K Hold
15,041
– – 0.04% 45
2024
Q2 		$36.7K Buy
15,041
+1,001
+7% +$3.56K 0.01% 134
2024
Q1 		$66.3K Hold
14,040
– – 0.03% 143
2023
Q4 		$64.6K Buy
+14,040
New +$46.4K 0.03% 125

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

One Wealth Management Investment & Advisory Services's NRXP Position: Q2 2026 in Review

One Wealth Management Investment & Advisory Services held its NRX Pharmaceuticals (NRXP) position steady in Q2 2026 at 43,309 shares worth $177K. The position accounts for 0.19% of the portfolio, ranked #52.

One Wealth Management Investment & Advisory Services first reported a position in NRXP in Q4 2023 and has held it in 11 quarters since. 46 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • One Wealth Management Investment & Advisory Services held 43,309 shares of NRX Pharmaceuticals worth $177K as of Q2 2026.
  • One Wealth Management Investment & Advisory Services left its NRX Pharmaceuticals share count unchanged in Q2 2026.
  • NRX Pharmaceuticals made up 0.19% of One Wealth Management Investment & Advisory Services's portfolio in Q2 2026, its #52 holding.
  • One Wealth Management Investment & Advisory Services first reported a position in NRX Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 46 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on One Wealth Management Investment & Advisory Services's 13F filing for Q2 2026, filed 13 Jul 2026.